HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarBacktestsPricing
Theme
Help Login Register
Market News Stocks News ETF News Crypto News

Stereotaxis, Inc.

Contributing Author

Recent Articles by Stereotaxis, Inc.

Oct-21
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025 STXS GlobeNewswire
Oct-15
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs STXS GlobeNewswire
Oct-13
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias STXS GlobeNewswire
Sep-22
Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System STXS GlobeNewswire
Sep-02
First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter STXS GlobeNewswire
Sep-02
Stereotaxis to Present at Upcoming Investor Conferences STXS GlobeNewswire
Aug-28
Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025 STXS GlobeNewswire
Aug-07
Stereotaxis Reports 2025 Second Quarter Financial Results STXS GlobeNewswire
Jul-28
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter STXS GlobeNewswire
Jul-23
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025 STXS GlobeNewswire
Jul-17
Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock STXS GlobeNewswire
Jul-01
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology STXS GlobeNewswire
May-12
Stereotaxis Reports 2025 First Quarter Financial Results STXS GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.

Learn more about FINVIZ*Elite